CSIMarket
 


Cardax Inc   (CDXI)
Other Ticker:  
 
 

CDXI's Operating Income Growth by Quarter and Year

Cardax Inc 's Operating Income results by quarter and year




CDXI Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -0.66 -0.72 -0.95
III Quarter September - -0.71 -1.19 -0.93
II Quarter June - -0.79 -1.05 -1.10
I Quarter March -0.77 -0.91 -1.11 -1.05
FY   -0.77 -3.07 -4.07 -4.03



CDXI Operating Income first quarter 2021 Y/Y Growth Comment
Cardax Inc in the first quarter 2021 recorded Operating Loss of $ -0.77 millions.

According to the results reported in the first quarter 2021, Cardax Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Cardax Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter 2021.

Explain Operating Income growth


CDXI Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cardax Inc 's first quarter 2021 Operating Income $ -0.77 millions CDXI's Income Statement
Cardax Inc 's first quarter 2020 Operating Income $ -0.91 millions Quarterly CDXI's Income Statement
New: More CDXI's historic Operating Income Growth >>


CDXI Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Cardax Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDXI's I. Quarter Q/Q Operating Income Comment
Recent results of -0.77 millions by Cardax Inc come out even less good compare to the Operating Loss -0.66 millions a quarter before.

Within Major Pharmaceutical Preparations industry Cardax Inc achieved highest sequential Operating Income growth. While Cardax Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDXI's I. Quarter Q/Q Operating Income Comment
Current Operating Loss of -0.77 millions by Cardax Inc come out even worse if you take a look at Operating Loss -0.66 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Cardax Inc achieved highest sequential Operating Income growth. While Cardax Inc 's Operating Income growth quarter on quarter, overall rank is .


Cardax Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Operating Income 12 Months Ending $ -2.93 $ -3.06 $ -3.12 $ -3.61 $ -3.87
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Cardax Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Cardax Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CDXI's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CDXI's Competitors
Operating Income Growth for Cardax Inc 's Suppliers
Operating Income Growth for CDXI's Customers

You may also want to know
CDXI's Annual Growth Rates CDXI's Profitability Ratios CDXI's Asset Turnover Ratio CDXI's Dividend Growth
CDXI's Roe CDXI's Valuation Ratios CDXI's Financial Strength Ratios CDXI's Dividend Payout Ratio
CDXI's Roa CDXI's Inventory Turnover Ratio CDXI's Growth Rates CDXI's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2021
National Healthcare Corp-3.69%$ -3.689 millions
Prestige Consumer Healthcare Inc -4.03%$ -4.032 millions
Baxter International Inc -4.65%$ -4.645 millions
Davita Inc -4.89%$ -4.894 millions
Phibro Animal Health Corporation-5.57%$ -5.568 millions
Steris Plc-7.41%$ -7.410 millions
Catalyst Pharmaceuticals Inc -8.40%$ -8.400 millions
Alexion Pharmaceuticals Inc -8.53%$ -8.526 millions
Amgen Inc -9.60%$ -9.597 millions
Carlisle Companies Incorporated-12.85%$ -12.853 millions
Amneal Pharmaceuticals Inc -20.56%$ -20.564 millions
Healthcare Services Group Inc -21.26%$ -21.259 millions
Merck and Co Inc -22.90%$ -22.896 millions
Atrion Corporation-23.76%$ -23.758 millions
Msa Safety Incorporated-25.08%$ -25.083 millions
Acadia Healthcare Company Inc -26.43%$ -26.425 millions
Eli Lilly And Company-27.38%$ -27.376 millions
Stryker Corp-27.72%$ -27.717 millions
Tempest Therapeutics Inc -29.44%$ -29.444 millions
Pacific Health Care Organization Inc -29.55%$ -29.552 millions
Lifevantage Corp-31.16%$ -31.157 millions
Teleflex Incorporated-34.15%$ -34.155 millions
Accuray Incorporated-44.46%$ -44.460 millions
Biogen Inc -46.49%$ -46.486 millions
Neurocrine Biosciences Inc -46.52%$ -46.520 millions
Corcept Therapeutics Inc-47.93%$ -47.925 millions
Musclepharm Corporation-50.64%$ -50.635 millions
Vyne Therapeutics Inc -51.29%$ -51.287 millions
Supernus Pharmaceuticals inc -54.45%$ -54.453 millions
Nuvasive Inc-56.43%$ -56.429 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com